Loading organizations...
§ Private Profile · Kitchener, ON, Canada
Biotech startup developing cultivated whole-cut meats from animal cells using cell sheet tissue engineering for sustainable protein.
CaroMeats, which now operates as Evolved Meats, is a biotechnology startup based in Kitchener-Waterloo, Ontario, that develops a species-agnostic platform to grow whole cuts of cultivated meat directly from animal cells. The company utilizes cell sheet tissue engineering to produce structurally and biochemically identical meat products, such as steak and pork belly, without the use of artificial scaffolds or animal slaughter. This production method aims to improve sustainability metrics by utilizing 99% less land and 96% less water compared to traditional agriculture. The seed-stage enterprise has raised $2 million CAD in early equity funding to support product development and production scale-up. This financing round was led by Maple Leaf Foods, with additional participation from Big Idea Ventures, Garage Capital, and Saltagen Ventures. The biotechnology company was established in an undisclosed year by co-founders Alireza Shahin and John Cappuccitti.
CaroMeats has raised $2.0M across 1 funding round.
CaroMeats has raised $2.0M in total across 1 funding round.
CaroMeats has raised $2.0M across 1 funding round. Most recently, it raised $2.0M Seed in May 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| May 1, 2022 | $2M Seed | Michael Mccain | Bessemer Venture Partners, BIG Idea Ventures, TET Ventures, Unovis Asset Management, Garage Capital, Saltagen Ventures, Velocity | Announced |
CaroMeats has raised $2.0M in total across 1 funding round.
CaroMeats's investors include Michael McCain, Bessemer Venture Partners, Big Idea Ventures, Tet Ventures, Unovis Asset Management, Garage Capital, Saltagen Ventures, Velocity.
Evolved Meats (formerly CaroMeats) is a Canadian biotechnology startup developing cultivated meat technology that grows whole cuts of real meat—such as steak, pork belly, chicken breast, or fish fillets—directly from a few animal cells using cell sheet tissue engineering.[1][2][3] It serves the food industry and consumers seeking sustainable alternatives to conventional meat, solving the problems of animal harm, high greenhouse gas emissions, excessive land and water use, and unsustainable protein production by creating 100% animal-cell products that match the texture, marbling, taste, mouthfeel, and nutrition of traditional meat without exogenous scaffolds or binders.[2][3][5] The company raised $2 million in seed funding in 2022, led by Maple Leaf Foods and Big Idea Ventures, to scale production and achieve cost parity with conventional meat, positioning it as a leader in the cultivated meat sector.[3][4][5]
Evolved Meats originated from innovations by CEO Alireza Shahin during his PhD and post-doctoral research at McMaster University, where he developed provisionally patented cell sheet engineering techniques to create functional tissues mimicking any meat cut from any species.[3][6] Co-founder and COO John Cappuccitti joined to focus on tissue assembly rather than cell proliferation, differentiating from competitors who rely on plant-based scaffolds yielding less than 70% animal cells.[2] Initially launched as CaroMeats in Kitchener-Waterloo, Ontario, the company rebranded to Evolved Meats and secured its $2 million seed round in 2022 from investors including Maple Leaf Foods, Big Idea Ventures, Garage Capital, Saltagen Ventures, University of Waterloo’s Velocity Fund, and angels, marking early traction in a crowded cultivated meat field.[3][4][5]
Evolved Meats rides the cultivated meat wave, addressing global protein demand amid climate pressures—livestock contributes significantly to emissions—by enabling sustainable, animal-free production at scale.[2][5] Timing aligns with maturing biotech tools like tissue engineering and investor interest from food giants like Maple Leaf Foods, which backs it to advance "the most sustainable protein company" vision.[3][6] Market forces favoring it include regulatory progress for cultivated meat approvals, consumer demand for ethical/high-quality alternatives, and sector funding despite crowding, where Evolved's scaffold-free, whole-cut focus provides a structural edge over cell-proliferation rivals.[2][7] It influences the ecosystem by pioneering Canadian commercialization of novel methods, potentially accelerating industry shift to biofabricated proteins.[7]
Evolved Meats is poised to scale production post-2022 funding, targeting commercial whole-cut launches and cost reductions via its modular tissue system, with potential for partnerships like Maple Leaf to fast-track market entry.[3][5] Trends like advancing bioreactor tech, falling culturing costs, and sustainability mandates will propel it, though competition and regulatory hurdles remain key risks. Its influence may grow by proving 100% cell-based meat viability, transforming food systems toward planet-friendly proteins—echoing its mission to deliver the sustainable food people deserve without compromise.[1][6]